Rici Healthcare Holdings Limited (HKG:1526)
Hong Kong · Delayed Price · Currency is HKD 0.8700
+0.0300 (3.57%)
At close: Mar 27, 2026
Rici Healthcare Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,796 | 2,924 | 2,993 | 2,375 | 2,377 | |
Revenue Growth (YoY) | -4.41% | -2.28% | 26.01% | -0.09% | 23.48% |
Cost of Revenue | 1,588 | 1,757 | 1,743 | 1,448 | 1,402 |
Gross Profit | 1,207 | 1,168 | 1,250 | 927.2 | 975.22 |
Selling, General & Admin | 545.21 | 566.99 | 604.43 | 509.26 | 471.34 |
Other Operating Expenses | -17.23 | -45.03 | -21.5 | -10.56 | -16.82 |
Operating Expenses | 527.99 | 540.77 | 591.97 | 495.25 | 454.52 |
Operating Income | 679.37 | 626.99 | 657.54 | 431.95 | 520.7 |
Interest Expense | -100.17 | -128.14 | -127.12 | -123.05 | -123.55 |
Interest & Investment Income | 5.91 | 4.87 | 10.37 | 6.42 | 6.95 |
Earnings From Equity Investments | -0.09 | 0.41 | 0.96 | 0.42 | 0.8 |
Currency Exchange Gain (Loss) | -3.38 | -0.72 | 4.5 | 11.73 | -8.51 |
EBT Excluding Unusual Items | 581.63 | 503.42 | 546.25 | 327.46 | 396.39 |
Gain (Loss) on Sale of Investments | -1.34 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | -0.75 | -0.62 | -0.27 | -4.32 |
Asset Writedown | -12.96 | -18.75 | - | - | - |
Pretax Income | 567.34 | 483.92 | 545.63 | 327.19 | 392.08 |
Income Tax Expense | 184.31 | 129.27 | 143.66 | 84.04 | 98.37 |
Earnings From Continuing Operations | 383.03 | 354.66 | 401.98 | 243.15 | 293.7 |
Earnings From Discontinued Operations | - | - | - | 24.04 | -167.6 |
Net Income to Company | 383.03 | 354.66 | 401.98 | 267.19 | 126.11 |
Minority Interest in Earnings | -75.9 | -57.33 | -38.17 | 23.61 | 55.45 |
Net Income | 307.13 | 297.32 | 363.8 | 290.79 | 181.55 |
Net Income to Common | 307.13 | 297.32 | 363.8 | 290.79 | 181.55 |
Net Income Growth | 3.30% | -18.27% | 25.11% | 60.17% | - |
Shares Outstanding (Basic) | 1,590 | 1,590 | 1,590 | 1,590 | 1,590 |
Shares Outstanding (Diluted) | 1,590 | 1,590 | 1,590 | 1,590 | 1,590 |
EPS (Basic) | 0.19 | 0.19 | 0.23 | 0.18 | 0.11 |
EPS (Diluted) | 0.19 | 0.19 | 0.23 | 0.18 | 0.11 |
EPS Growth | 3.30% | -18.27% | 25.11% | 60.17% | - |
Free Cash Flow | - | 584.97 | 487.07 | 396.33 | 356.41 |
Free Cash Flow Per Share | - | 0.37 | 0.31 | 0.25 | 0.22 |
Dividend Per Share | 0.020 | 0.042 | - | - | - |
Dividend Growth | -52.70% | - | - | - | - |
Gross Margin | 43.19% | 39.93% | 41.75% | 39.04% | 41.02% |
Operating Margin | 24.30% | 21.44% | 21.97% | 18.19% | 21.90% |
Profit Margin | 10.99% | 10.17% | 12.16% | 12.24% | 7.64% |
Free Cash Flow Margin | - | 20.00% | 16.28% | 16.69% | 14.99% |
EBITDA | 877.87 | 825.49 | 829.98 | 572.61 | 682.8 |
EBITDA Margin | 31.40% | 28.23% | 27.73% | 24.11% | 28.72% |
D&A For EBITDA | 198.5 | 198.5 | 172.44 | 140.67 | 162.11 |
EBIT | 679.37 | 626.99 | 657.54 | 431.95 | 520.7 |
EBIT Margin | 24.30% | 21.44% | 21.97% | 18.19% | 21.90% |
Effective Tax Rate | 32.49% | 26.71% | 26.33% | 25.69% | 25.09% |
Advertising Expenses | 91.7 | 117.29 | 114.93 | 68.61 | 70.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.